Page last updated: 2024-09-05

lixivaptan and Adverse Drug Event

lixivaptan has been researched along with Adverse Drug Event in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Klunk, L; Li, Z; Orlandi, C; Prakash, C1
Howell, BA; Pellegrini, L; Shoda, LKM; Woodhead, JL1

Other Studies

2 other study(ies) available for lixivaptan and Adverse Drug Event

ArticleYear
Assessment of exposure of metabolites in preclinical species and humans at steady state from the single-dose radiolabeled absorption, distribution, metabolism, and excretion studies: a case study.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:7

    Topics: Absorption; Adolescent; Adult; Animals; Area Under Curve; Benzamides; Carbon Radioisotopes; Case-Control Studies; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Inactivation, Metabolic; Male; Metabolome; Middle Aged; Pyrroles; Rats; Rats, Sprague-Dawley; Young Adult

2012
Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling.
    Pharmaceutical research, 2020, Jan-06, Volume: 37, Issue:2

    Topics: Benzamides; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Models, Theoretical; Polycystic Kidney, Autosomal Dominant; Pyrroles; Tolvaptan

2020